Actitud terapéutica ante un prolactinoma quístico gigante

Statistics

Carta al Editor

Therapeutic approach in a giant cystic prolactinoma

L. Arguinzoniza, M.T. Muñoz-Calvoa,b,c, J. Pozoa,b,c, G.A.. G.Á. Martos-Morenoa,b,c, J. Argentea,b,c,

Corresponding author

argentefen@terra.es

Autor para correspondencia.

a Servicio de Endocrinología, Hospital Infantil Universitario Niño Jesús, Madrid, España

b Universidad Autónoma de Madrid, Madrid, España

c Departamento de Pediatría, CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, España

Read

12302

Times
was read the article

3053

Total PDF

9249

Total HTML

Share statistics

Article information

ISSN: 16954033
Original language: Spanish

DOI:10.1016/j.anpedi.2010.07.014

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 April	79	36	115
2025 March	68	31	99
2025 February	112	26	138
2025 January	67	42	109
2024 December	81	29	110
2024 November	64	60	124
2024 October	57	39	96
2024 September	63	29	92
2024 August	60	43	103
2024 July	69	32	101
2024 June	60	43	103
2024 May	53	44	97
2024 April	65	36	101
2024 March	55	32	87
2024 February	92	27	119
2024 January	101	25	126
2023 December	100	20	120
2023 November	95	29	124
2023 October	103	29	132
2023 September	59	21	80
2023 August	67	30	97
2023 July	82	54	136
2023 June	72	42	114
2023 May	68	27	95
2023 April	64	23	87
2023 March	98	34	132
2023 February	67	31	98
2023 January	71	37	108
2022 December	75	37	112
2022 November	117	64	181
2022 October	110	64	174
2022 September	99	66	165
2022 August	76	74	150
2022 July	59	39	98
2022 June	73	41	114
2022 May	78	48	126
2022 April	80	40	120
2022 March	117	52	169
2022 February	92	56	148
2022 January	123	66	189
2021 December	79	43	122
2021 November	78	66	144
2021 October	99	55	154
2021 September	72	66	138
2021 August	72	41	113
2021 July	59	32	91
2021 June	80	39	119
2021 May	75	35	110
2021 April	138	99	237
2021 March	105	48	153
2021 February	74	35	109
2021 January	75	28	103
2020 December	81	29	110
2020 November	74	15	89
2020 October	133	28	161
2020 September	248	16	264
2020 August	84	12	96
2020 July	93	26	119
2020 June	93	11	104
2020 May	79	22	101
2020 April	52	24	76
2020 March	46	18	64
2020 February	49	10	59
2020 January	61	21	82
2019 December	67	27	94
2019 November	57	8	65
2019 October	50	23	73
2019 September	59	10	69
2019 August	49	15	64
2019 July	38	15	53
2019 June	97	38	135
2019 May	194	50	244
2019 April	158	38	196
2019 March	65	13	78
2019 February	59	21	80
2019 January	61	30	91
2018 December	60	26	86
2018 November	63	21	84
2018 October	64	19	83
2018 September	35	9	44
2018 August	9	0	9
2018 July	5	0	5
2018 June	5	0	5
2018 May	13	0	13
2018 April	30	0	30
2018 March	40	0	40
2018 February	20	0	20
2018 January	23	0	23
2017 December	13	0	13
2017 November	19	0	19
2017 October	16	0	16
2017 September	25	0	25
2017 August	22	0	22
2017 July	24	0	24
2017 June	22	6	28
2017 May	41	5	46
2017 April	39	8	47
2017 March	14	15	29
2017 February	73	2	75
2017 January	18	1	19
2016 December	39	10	49
2016 November	65	10	75
2016 October	55	12	67
2016 September	93	2	95
2016 August	52	8	60
2016 July	29	7	36
2016 June	2	0	2
2016 May	1	0	1
2016 April	2	0	2
2016 March	3	0	3
2016 February	1	0	1
2016 January	3	0	3
2015 December	3	0	3
2015 October	3	8	11
2015 September	2	0	2
2015 August	1	7	8
2015 July	11	10	21
2015 June	8	7	15
2015 May	20	1	21
2015 April	16	9	25
2015 March	14	0	14
2015 February	12	10	22
2015 January	12	1	13
2014 December	42	2	44
2014 November	19	0	19
2014 October	16	2	18
2014 September	25	2	27
2014 August	21	2	23
2014 July	25	1	26
2014 June	49	4	53
2014 May	55	3	58
2014 April	49	3	52
2014 March	55	10	65
2014 February	47	9	56
2014 January	44	6	50
2013 December	49	6	55
2013 November	44	12	56
2013 October	37	11	48
2013 September	22	10	32
2013 August	37	16	53
2013 July	23	10	33
2013 June	3	1	4
2013 May	6	1	7
2013 April	6	5	11
2013 March	11	4	15
2013 February	20	6	26
2013 January	47	2	49
2012 December	23	3	26
2012 November	5	2	7
2012 August	1	1	2
2010 November	1084	0	1084

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter